SOLV
Solventum Corporation
NYSEUSDEQUITY
DELAYED
Last price
89.57
▲ 0.96 (1.08%)
MARKET · —
Price
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
88.61
Prev close
88.61
Day high
89.65
Day low
88.00
Volume
730.81K
Market cap
—
P/E (TTM)
—
52W range
62.38 – 90.00
Trailing performance
Returnvs SPY
1W
+1.11%
+2.5%
1M
+15.96%
+12.2%
3M
+16.70%
+13.6%
6M
+22.80%
+11.7%
YTD
+13.04%
+0.7%
1Y
+22.95%
+3.0%
3Y
—
-74.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Free account
3 more panels on SOLV open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $8.32B | $8.25B | $8.20B | $8.13B | +0.9% |
| Operating revenue | $8.32B | $8.25B | $8.20B | $8.13B | +0.9% |
| Cost of revenue | $3.87B | $3.66B | $3.50B | $3.44B | +5.8% |
| Gross profit | $4.45B | $4.59B | $4.69B | $4.70B | -3.1% |
| Research & development | $739.00M | $775.00M | $758.00M | $767.00M | -4.6% |
| Selling, general & admin | $3.08B | $2.78B | $2.30B | $2.23B | +10.7% |
| Total operating expense | $3.82B | $3.56B | $3.06B | $3.00B | +7.4% |
| Operating income | $632.00M | $1.04B | $1.64B | $1.69B | -39.0% |
| Net interest income | -$347.00M | -$367.00M | $0 | $0 | +5.4% |
| Pre-tax income | $1.71B | $605.00M | $1.67B | $1.69B | +183.1% |
| Tax provision | $157.00M | $127.00M | $321.00M | $349.00M | +23.6% |
| Net income | $1.56B | $479.00M | $1.35B | $1.34B | +224.8% |
| Net income to common | $1.56B | $479.00M | $1.35B | $1.34B | +224.8% |
| Basic EPS | 8.94 | 2.77 | 7.79 | 7.78 | +222.7% |
| Diluted EPS | 8.88 | 2.76 | 7.79 | 7.78 | +221.7% |
| EBIT | $2.06B | $972.00M | $1.67B | $1.69B | +111.9% |
| EBITDA | $2.55B | $1.53B | $2.23B | $2.27B | +66.9% |
| Basic shares | 174.10M | 173.20M | 172.71M | 172.70M | +0.5% |
| Diluted shares | 175.30M | 173.70M | 172.71M | 172.70M | +0.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $878.00M | $762.00M | $194.00M | $61.00M | +15.2% |
| Cash & short-term investments | $878.00M | $762.00M | $194.00M | $61.00M | +15.2% |
| Accounts receivable | $1.03B | $1.04B | $1.31B | $1.17B | -1.0% |
| Inventory | $1.07B | $965.00M | $857.00M | $873.00M | +10.5% |
| Total current assets | $3.86B | $3.25B | $2.52B | $2.23B | +18.8% |
| Property, plant & equipment | $1.33B | $1.62B | $1.46B | $1.32B | -18.2% |
| Goodwill & intangibles | $8.30B | $8.92B | $9.44B | $9.69B | -7.0% |
| Total assets | $14.29B | $14.46B | $13.94B | $13.59B | -1.1% |
| Total current liabilities | $3.14B | $2.70B | $1.73B | $1.31B | +16.0% |
| Current debt | — | $200.00M | — | — | — |
| Long-term debt | $5.04B | $7.81B | $8.30B | — | -35.5% |
| Total debt | $5.04B | $8.01B | $8.30B | — | -37.1% |
| Total liabilities | $9.24B | $11.50B | $2.28B | $1.85B | -19.6% |
| Retained earnings | $1.80B | $242.00M | $0 | — | +642.6% |
| Shareholder equity | $5.05B | $2.96B | $11.67B | $11.74B | +70.7% |
| Working capital | $723.00M | $546.00M | $791.00M | $920.00M | +32.4% |
| Net tangible assets | -$3.25B | -$5.96B | $2.23B | $2.06B | +45.6% |
| Shares issued | 173.49M | 172.79M | 172.71M | 172.71M | +0.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $1.56B | $479.00M | $1.35B | $1.34B | +224.8% |
| Depreciation & amortisation | $489.00M | $555.00M | $561.00M | $578.00M | -11.9% |
| Stock-based compensation | $161.00M | $112.00M | $39.00M | $37.00M | +43.8% |
| Change in working capital | -$119.00M | $160.00M | $126.00M | -$202.00M | -174.4% |
| Operating cash flow | $369.00M | $1.19B | $1.92B | $1.68B | -68.9% |
| Capital expenditure | -$379.00M | -$380.00M | -$290.00M | -$251.00M | +0.3% |
| Investing cash flow | $2.80B | -$380.00M | -$230.00M | -$253.00M | +836.1% |
| Financing cash flow | -$3.06B | -$240.00M | -$1.55B | -$1.46B | -1,173.8% |
| Free cash flow | -$10.00M | $805.00M | $1.63B | $1.43B | -101.2% |
| End cash position | $878.00M | $762.00M | $194.00M | $61.00M | +15.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $2.21B | $2.01B | $2.00B | $2.10B | $2.16B | +10.1% |
| Operating revenue | $2.21B | $2.01B | $2.00B | $2.10B | $2.16B | +10.1% |
| Cost of revenue | $923.00M | $911.00M | $971.00M | $961.00M | $986.00M | +1.3% |
| Gross profit | $1.29B | $1.09B | $1.03B | $1.14B | $1.18B | +17.4% |
| Research & development | $178.00M | $189.00M | $175.00M | $183.00M | $189.00M | -5.8% |
| Selling, general & admin | $927.00M | $827.00M | $759.00M | $780.00M | $772.00M | +12.1% |
| Total operating expense | $1.10B | $1.02B | $934.00M | $963.00M | $961.00M | +8.8% |
| Operating income | $181.00M | $79.00M | $93.00M | $172.00M | $214.00M | +129.1% |
| Net interest income | -$64.00M | -$62.00M | -$51.00M | -$89.00M | -$103.00M | -3.2% |
| Pre-tax income | $108.00M | $16.00M | $58.00M | $1.51B | $103.00M | +575.0% |
| Tax provision | $15.00M | $3.00M | -$5.00M | $248.00M | $13.00M | +400.0% |
| Net income | $92.00M | $13.00M | $63.00M | $1.27B | $90.00M | +607.7% |
| Net income to common | $92.00M | $13.00M | $63.00M | $1.27B | $90.00M | +607.7% |
| Basic EPS | 0.53 | 0.07 | 0.36 | 7.26 | 0.52 | +657.1% |
| Diluted EPS | 0.53 | 0.07 | 0.36 | 7.22 | 0.51 | +657.1% |
| EBIT | $172.00M | $78.00M | $109.00M | $1.60B | $206.00M | +120.5% |
| EBITDA | $305.00M | $213.00M | $226.00M | $1.72B | $328.00M | +43.2% |
| Basic shares | 172.70M | 174.20M | 174.40M | 174.30M | 174.10M | -0.9% |
| Diluted shares | 173.30M | 175.50M | 175.70M | 175.40M | 175.20M | -1.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $403.00M | $561.00M | $878.00M | $1.64B | $492.00M | — | -28.2% |
| Cash & short-term investments | $403.00M | $561.00M | $878.00M | $1.64B | $492.00M | — | -28.2% |
| Accounts receivable | $1.31B | $1.06B | $1.03B | $1.02B | $1.06B | — | +23.7% |
| Inventory | $1.04B | $1.09B | $1.07B | $1.05B | $962.00M | — | -4.5% |
| Total current assets | $3.74B | $3.58B | $3.86B | $4.41B | $3.21B | — | +4.4% |
| Property, plant & equipment | $1.75B | $1.73B | $1.33B | $1.34B | $1.31B | — | +1.4% |
| Goodwill & intangibles | $8.03B | $8.12B | $8.30B | $7.48B | $7.58B | — | -1.1% |
| Total assets | $14.24B | $14.10B | $14.29B | $13.97B | $15.07B | — | +1.0% |
| Total current liabilities | $3.66B | $3.35B | $3.14B | $2.94B | $2.62B | — | +9.5% |
| Current debt | $506.00M | $505.00M | — | — | — | $100.00M | +0.2% |
| Long-term debt | $4.57B | $4.58B | $5.04B | $5.14B | $7.82B | — | -0.0% |
| Total debt | $5.29B | $5.29B | $5.04B | $5.14B | $7.82B | — | -0.0% |
| Total liabilities | $9.44B | $9.13B | $9.24B | $8.99B | $11.43B | — | +3.5% |
| Retained earnings | $1.90B | $1.81B | $1.80B | $1.73B | $468.00M | — | +5.1% |
| Shareholder equity | $4.80B | $4.97B | $5.05B | $4.99B | $3.65B | — | -3.4% |
| Working capital | $78.00M | $237.00M | $723.00M | $1.47B | $588.00M | — | -67.1% |
| Net tangible assets | -$3.23B | -$3.15B | -$3.25B | -$2.50B | -$3.93B | — | -2.6% |
| Shares issued | 170.11M | 174.45M | 173.49M | 173.44M | 173.39M | — | -2.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | $92.00M | $13.00M | $63.00M | $1.27B | $90.00M | — | +607.7% |
| Depreciation & amortisation | $133.00M | $135.00M | $117.00M | $121.00M | $122.00M | — | -1.5% |
| Stock-based compensation | $38.00M | $51.00M | $37.00M | $41.00M | $34.00M | — | -25.5% |
| Change in working capital | -$5.00M | -$360.00M | -$6.00M | $105.00M | -$61.00M | — | +98.6% |
| Operating cash flow | $227.00M | -$189.00M | $95.00M | $76.00M | $169.00M | — | +220.1% |
| Capital expenditure | -$83.00M | -$84.00M | -$63.00M | -$97.00M | -$110.00M | — | +1.2% |
| Investing cash flow | -$87.00M | -$77.00M | -$745.00M | $3.77B | -$110.00M | — | -13.0% |
| Share buybacks | -$288.00M | -$67.00M | — | — | $0 | $0 | -329.9% |
| Financing cash flow | -$300.00M | -$50.00M | -$115.00M | -$2.69B | -$110.00M | — | -500.0% |
| Free cash flow | $144.00M | -$273.00M | $32.00M | -$21.00M | $59.00M | — | +152.7% |
| End cash position | $403.00M | $561.00M | $878.00M | $1.64B | $492.00M | — | -28.2% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
86.99
+2.96% from price
SMA 20
86.34
+3.74% from price
SMA 50
80.98
+10.61% from price
SMA 100
76.38
+17.27% from price
SMA 200
76.42
+17.21% from price
EMA 12
87.00
+2.96% from price
EMA 26
84.83
+5.58% from price
EMA 50
82.07
+9.14% from price
RSI (14)
63.7
Neutral
MACD (12,26,9)
2.16
Hist 0.11
ATR (14)
2.86
3.20% of price
Realised vol 30D
37.0%
Annualised
Bollinger upper
90.85
20, 2σ
Bollinger lower
81.83
20, 2σ
50 / 200 cross
Golden
80.98 vs 76.42
Trend bias
Above 200
+17.21%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.64
Less volatile than market
Correlation to SPY
0.27
Largely independent
Realised vol 30D
37.0%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-27.5%
Peak to trough
Max drawdown 5Y
-40.0%
Peak to trough
ATR 14
2.86
3.20% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
1 Healthcare Stock for Long-Term Investors and 2 Facing Challenges
StockStory · 3d ago
SOLV Plans Health Information Systems Business Spinoff to Drive Growth
Zacks · 9d ago
Are Wall Street Analysts Bullish on Solventum Stock?
Barchart · 9d ago
Solventum (SOLV) Q2 2026 Earnings Call Transcript
Motley Fool · 10d ago
SOLV Q2 Deep Dive: Portfolio Restructuring and ERP Transition Shape Outlook
StockStory · 12d ago
Solventum (SOLV) Stock Fair Value Rises After Q2 And HIS Separation Plans
Simply Wall St. · 14d ago
Solventum Q2 Earnings Call Highlights
MarketBeat · 14d ago
Solventum Stock Up as Q2 Earnings & Revenues Beat Estimates
Zacks · 16d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.